A Fecal Microbiota Signature with High Specificity for Pancreatic Cancer
3 institutional releases
Published in Gut · View the paper (DOI)
Researchers have identified a genetic signature of 27 microorganisms in stool samples that can predict the risk of pancreatic ductal adenocarcinoma and diagnose patients with earlier stages of the disease. This breakthrough could lead to an effective, non-invasive way to detect pancreatic cancer early.
Coverage from 3 institutions
- Microorganisms in stool samples could offer new way to detect pancreatic cancer early Worldwide Cancer Research · Mar 8, 2022 · first to report
- Distinct gut microbial profile may identify pancreatic cancer, irrespective of stage BMJ Group · Mar 8, 2022
- An international study proposes stool analysis for early detection of pancreatic cancer Centro Nacional de Investigaciones Oncológicas (CNIO) · Mar 8, 2022